Girish Modi to Animals
This is a "connection" page, showing publications Girish Modi has written about Animals.
Connection Strength
0,441
-
Synthesis, Characterisation and In Vitro Permeation, Dissolution and Cytotoxic Evaluation of Ruthenium(II)-Liganded Sulpiride and Amino Alcohol. Sci Rep. 2019 03 11; 9(1):4146.
Score: 0,032
-
Targeted Delivery of Amantadine-loaded Methacrylate Nanosphere-ligands for the Potential Treatment of Amyotrophic Lateral Sclerosis. J Pharm Pharm Sci. 2018; 21(1):94-109.
Score: 0,030
-
Development of a Gastric Absorptive, Immediate Responsive, Oral Protein-Loaded Versatile Polymeric Delivery System. AAPS PharmSciTech. 2017 Oct; 18(7):2479-2493.
Score: 0,028
-
In Vitro and In Vivo Evaluation of a Hydrogel-Based Microneedle Device for Transdermal Electro-Modulated Analgesia. J Pharm Sci. 2017 04; 106(4):1111-1116.
Score: 0,028
-
Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders. Drug Discov Today. 2016 12; 21(12):1886-1914.
Score: 0,027
-
Implantable and transdermal polymeric drug delivery technologies for the treatment of central nervous system disorders. Pharm Dev Technol. 2017 Jun; 22(4):476-486.
Score: 0,026
-
Functionalized Nanolipobubbles Embedded Within a Nanocomposite Hydrogel: a Molecular Bio-imaging and Biomechanical Analysis of the System. AAPS PharmSciTech. 2017 Apr; 18(3):671-685.
Score: 0,026
-
Ex vivo evaluation of a microneedle array device for transdermal application. Int J Pharm. 2015 Dec 30; 496(2):351-9.
Score: 0,025
-
Development and in vivo evaluation of an implantable nano-enabled multipolymeric scaffold for the management of AIDS dementia complex (ADC). Int J Pharm. 2015 Dec 30; 496(2):863-77.
Score: 0,025
-
A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. J Pharm Sci. 2015 Apr; 104(4):1213-29.
Score: 0,024
-
Multifunctional therapeutic delivery strategies for effective neuro-regeneration following traumatic spinal cord injury. Curr Pharm Des. 2015; 21(12):1517-28.
Score: 0,024
-
Current advances in the fabrication of microneedles for transdermal delivery. J Control Release. 2014 Jul 10; 185:130-8.
Score: 0,023
-
A novel pH-sensitive interferon-ß (INF-ß) oral delivery system for application in multiple sclerosis. Int J Pharm. 2013 Nov 18; 456(2):459-72.
Score: 0,022
-
A review of integrating electroactive polymers as responsive systems for specialized drug delivery applications. J Biomed Mater Res A. 2014 Jun; 102(6):2039-54.
Score: 0,022
-
Ligand-functionalized nanoliposomes for targeted delivery of galantamine. Int J Pharm. 2013 May 01; 448(1):267-81.
Score: 0,021
-
Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease. AAPS PharmSciTech. 2013 Jun; 14(2):605-19.
Score: 0,021
-
Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with ß-amyloid aggregates of Alzheimer's disease. Pharm Res. 2012 Nov; 29(11):3075-89.
Score: 0,020
-
Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain. Int J Pharm. 2009 Dec 01; 382(1-2):277-90.
Score: 0,017